Also known as glutamate-oxaloacetate transaminase, AST, and GOT.
Post hoc ESSENCE subgroup (n=106) showed improvements in ALT, AST, FAST, ELF and PRO‑C3 at week 72 versus placebo; findings presented at AASLD 2026.
